General
Preferred name
CEFODIZIME
Synonyms
CEF, CDZ ()
HR 221 ()
Timecef ()
HR 221 [AS SODIUM] ()
THR-221 ()
THR 221 [AS SODIUM] ()
S 77-1221B ()
HR-221 ()
Cefodizime disodium ()
S 77 1221 B ()
Cefodizime disodium salt ()
Cefodizime Sodium ()
S-77-1221B ()
S 77 1221 B [AS SODIUM] ()
THR 221 ()
S-77-1221-B ()
Cefodizima ()
P&D ID
PD072139
CAS
69739-16-8
Tags
available
drug
First approval
1991
Drug indication
Bacterial infections
Drug Status
experimental
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Cefodizime is a third generation cephalosporin belonging to the β-lactam class of antibacterial compounds.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
12
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
30
Molecular Weight
584.03
Hydrogen Bond Acceptors
13
Hydrogen Bond Donors
4
Rotatable Bonds
10
Ring Count
4
Aromatic Ring Count
2
cLogP
1.0
TPSA
197.4
Fraction CSP3
0.35
Chiral centers
2.0
Largest ring
6.0
QED
0.13
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Indication
respiratory tract infections, skin infections, gonorrhea
MOA
bacterial cell wall synthesis inhibitor
Pathway
Anti-infection
Therapeutic Class
Anti-Bacterial Agents
Target
antibiotic
Bacterial
Penicillin-binding protein (PBP)
Source data
